
Overview
Ti-Com is a Contract Research Organization that specializes in preclinical research using large animal models to test drugs and medical devices for central nervous system diseases. They utilize image-guided procedures, particularly an endovascular model of stroke in pigs, to enhance precision in testing biomarkers, diagnostics, and therapeutic agents. Their services include project logistics management and behavioral testing to support the development of new treatments.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 40 days late).
- 202501/04/2026
- 202418/06/2025
- 202302/07/2024
- 202213/07/2023
- 202124/08/2022
- 202019/02/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

SNOSSA Meeting 2024
The 7th Annual Meeting of the Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA) was held in Harare, the capital of Zimbabwe, from July 25 to 27, 2024.

SIGN Meeting 2024
Early in 2024, the Society for Image-Guided Neurointerventions (SIGN) held its conference in the stunning and exotic Ramoji Film City, just outside Hyderabad,

Ti-com at Invest Cuffs 2023
Ti-com seeks investment at Invest Cuffs in Cracow. It is the biggest business conference in Poland, at a spectacular ICE Congress Centre.

SIGN Meeting 2022
Two weeks ago we had the opportunity to be part of an incredibly interesting conference Society for Image-Guided Neurointerventions (SIGN) in the
Industry
Offer
- Preclinical testing
- Stroke models
- Drug testing
- Medical device testing
- Image-guided neurointerventions
- Histopathological examinations
Websites
- ticomglobal.comTi-comWordPress 7.1RRank MathNginx
Job offers
The company has its own careers page: ticomglobal.com/about-us.
Authorized Representatives
Manner of representation
The persons authorised to make declarations of will in property and non-property matters and to sign on behalf of the company are: in the event of a one-person management board – a member of the management board independently; in the event of a multi-member management board – two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dominika Gołubczyk age 34 | 39 | $526.74 | 19.5% |
Mirosław Janowski age 51 | 80 | $1,080.50 | 40% |
Piotr Walczak age 50 | 75 | $1,012.97 | 37.5% |
Maciej Daciewicz | 6 | $81.04 | 3% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-12-10.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 2, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Olsztyn |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-01-01 | Engineering vascularized implants for personalised osteochondral tissue regeneration: from medical imaging to pre-clinical validation | $114.3K$114,283 | 1.0.11 - Horizon Europe |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MDR Regulator sp. z o.o. | $377,079.69 | pureclinical.eu | ||
| Green Zebras S.A. | $328,658.91 | whygreenzebras.pl | ||
| Globe Badania Kliniczne sp. z o.o. | $283,646.38 | globebadania.pl | ||
| Genelytica sp. z o.o. | $213,207.91 | genelytica.pl | ||
| TCI sp. z o.o. | $218,471.87 | tci.pl | ||
| Pharmaxi Poland sp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Clinical Medical Research II sp. z o.o. | $124,693.62 | clinicalmedicalresearch.pl | ||
| Centrum Analiz Sądowych i Badań Kryminalistycznych sp. z o.o. | $116,835.50 | cbk-poznan.pl | ||
| HTA Registry sp. z o.o. | $96,615.01 | htaregistry.pl | ||
| Zawamed sp. z o.o. | $43,909.06 | zawamed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-08-24 | Share capital increase (5,000.00 PLN → 10,000.00 PLN) | |
| 2018-07-23 | Entered in the register |
FAQ
Last updated: 2026-04-02
